Reversing dementia in mice sets stage for human clinical trials
New Atlas - 29-Jun-2021SAK3, the first compound to target the activity in neurodegenerative disorders
Join the club for FREE to access the whole archive and other member benefits.
Japanese national university.
In the more than 100 years since Tohoku University was founded in 1907, the constant goal has been to become one of the world's great research universities.
We take great pride in the past successes of our students and faculty. Their innovations in science and engineering have helped make the world a better place in which to live. We learned, however, through the 3-11-11 disaster that there is so much more we can do to develop new technologies which will make the entire world safer and more environmentally friendly. We welcome you to join us in pursuing this great challenge.
Visit website: http://www.tohoku.ac.jp/en/
Details last updated 23-Oct-2020
SAK3, the first compound to target the activity in neurodegenerative disorders
Protects cochlea during ageing; potential treatment strategies to prevent deafness
Could be used as artificial white blood cells defending your body from disease. Uses different p...